The EU is becoming an unconditional lobbyist for mRNA treatments. At the end of February, the EMA recommended for the first time the approval of a combined influenza-COVID vaccine from Moderna. Market approval is now only a formality, and the EU is set to become a global pioneer in this field.

read here (https://tkp-at.translate.goog/2026/03/05/eu-wird-mrna-hochburg/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp) (translated into English)